CERENO SCIENTIFIC AB B Cash Flow-to-Debt Ratio
CERENO SCIENTIFIC AB B cash flow-to-debt ratio. CERENO SCIENTIFIC AB B (4A1) has a Cash Flow-to-Debt Ratio of 0.08x as of June 2026, meaning its operating cash flow of €20.90 Million could theoretically repay 0% of its total liabilities (€261.12 Million) in one year. Check 4A1 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CERENO SCIENTIFIC AB B (2021–2025)
Cash flow-to-debt ratio of CERENO SCIENTIFIC AB B from 2021 to 2025. Historical debt coverage capacity for CERENO SCIENTIFIC AB B across 5 annual periods. See CERENO SCIENTIFIC AB B net asset quality index to measure how much of total assets are equity-financed.
CERENO SCIENTIFIC AB B Cash Flow-to-Debt Ratio by Year (2021–2025)
CERENO SCIENTIFIC AB B cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for CERENO SCIENTIFIC AB B. For the full cash flow conversion analysis, see CERENO SCIENTIFIC AB B cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.75x | €-111.93 Million | €150.08 Million | ▼ -60.0% |
| 2024 | -0.47x | €-103.42 Million | €221.85 Million | ▲ +13.4% |
| 2023 | -0.54x | €-36.92 Million | €68.56 Million | ▲ +59.1% |
| 2022 | -1.32x | €-18.62 Million | €14.14 Million | ▼ -6.9% |
| 2021 | -1.23x | €-13.14 Million | €10.67 Million | — |